---
title: "Touyun Biotech Forecasts Swing to 2025 Profit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280463973.md"
description: "Touyun Biotech Forecasts Swing to 2025 Profit"
datetime: "2026-03-25T11:31:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280463973.md)
  - [en](https://longbridge.com/en/news/280463973.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280463973.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/280463973.md) | [繁體中文](https://longbridge.com/zh-HK/news/280463973.md)


# Touyun Biotech Forecasts Swing to 2025 Profit

Touyun Biotech Forecasts Swing to 2025 Profit

### Related Stocks

- [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md)
- [TOUYUN BIOTECH (01332.HK)](https://longbridge.com/en/quote/01332.HK.md)

## Related News & Research

- [Novo Nordisk Wins FDA Nod for First Once‑Weekly Basal Insulin Awiqli in U.S.](https://longbridge.com/en/news/280789111.md)
- [Insmed Sees Rising Physician Adoption of Brinsupri, Morgan Stanley Says](https://longbridge.com/en/news/281049788.md)
- [Iterum Therapeutics Announces Filing of Winding Up Petition | ITRM Stock News](https://longbridge.com/en/news/280800007.md)
- [Revolution Medicines' Readout of Trial for Pancreatic Cancer Drug Likely Positive, Oppenheimer Says](https://longbridge.com/en/news/281049250.md)
- [EXCLUSIVE: Penny Stock Scienture Reports Revenue Surge, Expanding Market Access In 2025](https://longbridge.com/en/news/281015927.md)